Ben Tre Pharmaceutical JSC (HOSE: DBT)
12,550
Open12,600
High12,600
Low12,550
Vol2,900
Market Cap.204.88
Remain Bid2,300
Remain Ask11,000
52Wk High14,400
52Wk Low11,000
52Wk Avg Vol15,006
Foreign Buy-
Frgn Owned(%)1.32
Dividend
Dividend Yield-
Beta-0.07
EPS947
P/E13.31
F P/E4.85
BVPS15,137
P/B0.83
- Overview
- Trading
- Technical Analysis
- Financials
- Profile
- News & Events
- Industry Peers
- Documents
- Internal Trading
- Bonds
| Date | Close | Change | Volume |
|---|---|---|---|
| 04/24/2024 | 12,550 | -50 (-0.40%) | 2,900 |
| 04/23/2024 | 12,600 | -100 (-0.79%) | 3,200 |
| 04/22/2024 | 12,700 | 0 (0.00%) | 10,600 |
| 04/19/2024 | 12,700 | 350 (+2.83%) | 13,300 |
| 04/17/2024 | 12,350 | 0 (0.00%) | 3,300 |
| 09/22/2023 | DBT: Loan at VIBank |
| 09/19/2023 | DBT: Change in the 22nd Business Registration Certificate |
| 09/12/2023 | DBT: Amending charter |
| 09/06/2023 | DBT: Change in content of business registration |
| 08/30/2023 | DBT: BOD Resolution on bank loan |
| 01/30/2023 | DBT Dividend payment by share with 10.00% for 2021 (Record date) |
| 02/19/2021 | DBT Dividend payment in cash with 7.00% for 2020 (Record date) |
| 02/19/2021 | DBT Dividend payment in cash with 7.00% for 2020 |
| 01/05/2021 | DBT Bonus share issue with 5.00% |
| 10/30/2019 | DBT Dividend payment in cash with 10.00% for 2019 (Record date) |
| 04/05/2024 | 2024 Annual Shareholders’Meeting Documents |
| 04/01/2024 | Audited Parent Company FS 2023 |
| 04/01/2024 | Audited Consolidated FS 2023 |
| 04/01/2024 | Explanation for Audited FS 2023 |
| 03/05/2024 | Parent Company FS Quarter 4 of 2023 |
Name: Ben Tre Pharmaceutical JSC
Abbreviation:Bepharco
Address: No.6A3 National Hightway 60, Phu Tan Ward Ben Tre Ben Tre
Telephone: (84.275) 822 429 - 813 447 - 829 528
Fax: (84.275) 824 248
Email:bepharco@vnn.vn
Website:http://bepharco.com
Exchange: HOSE
Sector: Manufacturing
Industry: Chemical - Pharmaceutical
Listing date: 10/28/2020
Chartered capital: 163,254,770,000
Listed shares: 16,325,477
Shares outstanding: 16,325,477
Status: Operating
Tax code: 1300382591
Establishment license: 1541/QĐ-UB
Issued date: 05/06/2004
Business license: 1300382591
Issued date: 07/05/2004
Main business scope:
- Manufacturing and trading drugs which treat humans being diseases
- Importing and exporting end-product drug and packages.
- Trading medical machines and equipment.
- Trading functional foods.
- 1983: Ben Tre Pharmaceutical trust-company was established;
- 1992: Renamed as Pharmaceutical and Medical material company (Bepharco) with the capital of VND5.6 billion;
- 2004: Transformed into a joint stock company with a charter capital of VND20 billion;
- 2007: Increased the charter capital to VND30 billion;
- 2009: Listed on Hanoi Stock Exchange (HNX);
- October 01, 2019: Increased the charter capital to VND135,28 billion;
- October 20, 2020: Delisted from Hanoi Stock Exchange (HNX);
- Ocotber 28, 2020: Traded on Ho Chi Minh Stock Exchange (HOSE);
- February 03, 2021: Increased the charter capital to VND142,051,160,000;
- 08/12/2024 DBT Annoucement of the change of listing - 700,000 shares
- 04/25/2024 DBT General Meeting of Shareholders for 2024
- 10/06/2023 DBT Decision on the change of listing - 700,000 shares
- 05/09/2023 DBT General Meeting of Shareholders for 2023
- 03/24/2023 DBT Annoucement of the change of listing - 1,420,361 shares
| Items | Unit |
|---|---|
| Price | VND |
| Volume | Shares |
| Foreigner's, Yield | % |
| Mkt Cap | bVND |
| Financial indicators | mVND |
| EPS, BVPS, Dividend | VND |
| P/E, F P/E, P/B | Times |
| ROS, ROA, ROE | % |
2. F PE is taken from the estimates of earnings announced by listed companies.
3. 3-month/6-month/12-month price charts are compiled from revised data.
